WC
Wesley Clark
Director

Wesley Clark insider trades: ImmunityBio (IBRX) stock buys and sales

Director, ImmunityBio Last trade Jun 1, 2023 46 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2007
13
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Wesley reports to the SEC

and 7 more companies

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 1, 2023IBRX↑ Buy$20K
May 26, 2016RTNB↓ Sell$30K
May 25, 2016RTNB↓ Sell$30K
May 17, 2016RTNB↓ Sell$22K
May 11, 2016RTNB↓ Sell$45K
Apr 29, 2016RTNB↓ Sell$12K
Jun 26, 2015RTNB↑ Buy$4K
Jun 26, 2015RTNB↑ Buy$3K
Dec 24, 2013JUHL.0B↑ Buy$5K
Aug 12, 2010RODM↑ Buy$16K
May 20, 2009JUHL↑ Buy$10K
Oct 15, 2007RODM↑ Buy$50K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other IBRX insiders

Open-market trades in the last 12 months

About Wesley Clark's insider trades

Wesley Clark is a director at ImmunityBio (IBRX). Since Oct 15, 2007, Wesley has reported 7 open-market purchases worth $109K and 5 sales worth $138K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (27 filings), option exercises (11 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IBRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.